MARKET

BLFS

BLFS

BioLife
NASDAQ

Real-time Quotes | Nasdaq Last Sale

29.11
+0.41
+1.43%
After Hours: 29.11 0 0.00% 16:43 01/24 EST
OPEN
27.99
PREV CLOSE
28.70
HIGH
29.16
LOW
25.93
VOLUME
619.07K
TURNOVER
--
52 WEEK HIGH
60.67
52 WEEK LOW
25.93
MARKET CAP
1.21B
P/E (TTM)
311.34
1D
5D
1M
3M
1Y
5Y
BioLife Solutions Collaborates With Seattle Children's To Improve Viral Vector And Cell Gene Therapy Manufacturing
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, today announced an extended collaboration with
Benzinga · 01/04 13:08
BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, today announced an extended collaboration with Seattle Children's Therapeutics, a ven...
PR Newswire · 01/04 13:06
Biolife Solutions Inc (BLFS) CEO Michael Rice Sold $1.1 million of Shares
CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 33,332 shares of BLFS on 12/15/2021 at an average price of $33.31 a share.
GuruFocus.com · 12/16/2021 15:15
BRIEF-Unicef Selects Ultra-Low Temperature Freezers From Biolife Solutions To Extend Thermal Stability Of Covid-19 Vaccines
reuters.com · 12/16/2021 13:17
UNICEF Selects Ultra-Low Temperature (ULT) Freezers from BioLife Solutions to Extend Thermal Stability of COVID-19 Vaccines
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced a partnership with UNICEF to extend thermal stability of te...
PR Newswire · 12/16/2021 13:03
Biolife Solutions Inc (BLFS) CEO Michael Rice Sold $821,403 of Shares
CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 22,925 shares of BLFS on 12/09/2021 at an average price of $35.83 a share.
GuruFocus.com · 12/10/2021 15:15
Biolife Solutions Inc (BLFS) EVP & Chief Scientific Officer Aby J. ...
EVP & Chief Scientific Officer of Biolife Solutions Inc (30-Year Financial, Insider Trades) Aby J. Mathew (insider trades) sold 18,853 shares of BLFS on 12/08/2021 at an average price of $35.38 a share.
GuruFocus.com · 12/09/2021 14:15
COO Of Biolife Solutions Makes $1.1M Sale
De De, COO at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that De sold 21,000 shares of Biolife...
Benzinga · 11/19/2021 16:50
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BLFS. Analyze the recent business situations of BioLife through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

11.11%Strong Buy
66.67%Buy
22.22%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BLFS stock price target is 63.43 with a high estimate of 68.00 and a low estimate of 60.00.
High68.00
Average63.43
Low60.00
Current 29.11
EPS
Actual
Estimate
-0.09-0.010.070.16
Q4 2020
Q1 2021
Q2 2021
    0
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 195
Institutional Holdings: 33.62M
% Owned: 80.72%
Shares Outstanding: 41.65M
TypeInstitutionsShares
Increased
53
5.12M
New
44
1.33M
Decreased
44
2.49M
Sold Out
10
55.89K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.10%
Healthcare Equipment & Supplies
-0.18%
Key Executives
Chairman/Chief Executive Officer/Director
Michael Rice
President/Chief Operating Officer
Roderick de Greef
Chief Financial Officer
Troy Wichterman
Executive Vice President/Chief Scientific Officer
Aby Mathew
Chief Marketing Officer
Todd Berard
Vice President/Director of Human Resources
Sarah Aebersold
Other
Karen Foster
Other
Marcus Schulz
Independent Director
Amy DuRoss
Independent Director
Rachel Ellingson
Independent Director
Joydeep Goswami
Independent Director
Joseph Schick
No Data
About BLFS
BioLife Solutions, Inc. is engaged in developing, manufacturing, and marketing bioproduction tools and services to the cell and gene therapy (CGT) industry. Its products are used in basic and applied research, and commercial manufacturing of biologic-based therapies. The customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution of cells and tissues. It has a portfolio of tools and services that focus on biopreservation, frozen storage, and thawing of biologic materials. Its product offerings under bioproduction tools and services include Biopreservation media, Automated thawing devices, Cloud connected smart shipping containers, Freezer and storage technology and related components, and Biological and pharmaceutical material storage. Its Biopreservation media products consists of HypoThermosol FRS and CryoStor. Its Astero ThawSTAR product line includes automated vial and cryobag thawing products.

Webull offers kinds of BioLife Solutions Inc stock information, including NASDAQ:BLFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLFS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLFS stock methods without spending real money on the virtual paper trading platform.